Phosphodiesterases as therapeutic targets (Q35096807)

6 August 2017

1 reference

title

Phosphodiesterases as therapeutic targets (English)

1 reference

6 August 2017

Ching-Shwun Lin

1

1 reference

6 August 2017

Zhong-Cheng Xin

series ordinal

2

1 reference

6 August 2017

Guiting Lin

series ordinal

3

1 reference

6 August 2017

Tom F Lue

series ordinal

4

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

61

1 reference

6 August 2017

issue

4

1 reference

6 August 2017

page(s)

685-691

1 reference

Cyclic nucleotide phosphodiesterases: relating structure and function

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902439-1

7 January 2021

The Sequence of the Human Genome

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902439-1

7 January 2021

Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902439-1

7 January 2021

Subcellular localization of rolipram-sensitive, cAMP-specific phosphodiesterases. Differential targeting and activation of the splicing variants derived from the PDE4D gene

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902439-1

7 January 2021

The RACK1 signaling scaffold protein selectively interacts with the cAMP-specific phosphodiesterase PDE4D5 isoform

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902439-1

7 January 2021

Conformational difference between PDE4 apoenzyme and holoenzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902439-1

7 January 2021

Human PDE5A gene encodes three PDE5 isoforms from two alternate promoters

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902439-1

7 January 2021

Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902439-1

7 January 2021

The next generation of PDE4 inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902439-1

7 January 2021

On the medical history of xanthines and other remedies for asthma: a tribute to HH Salter

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902439-1

7 January 2021

G proteins and phototransduction.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902439-1

7 January 2021

Potential role of phosphodiesterase 7 in human T cell function: comparative effects of two phosphodiesterase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902439-1

7 January 2021

Cyclic GMP phosphodiesterase-5: target of sildenafil

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902439-1

7 January 2021

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902439-1

7 January 2021

The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902439-1

7 January 2021

The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902439-1

7 January 2021

Expression of different phosphodiesterase genes in human cavernous smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902439-1

7 January 2021

Effects of sildenafil on cAMP and cGMP levels in isolated human cavernous and cardiac tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902439-1

7 January 2021

Future drugs for the treatment of benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902439-1

7 January 2021

The basis for drug treatment of the overactive bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902439-1

7 January 2021

Cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human detrusor smooth muscle. I. Identification and characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902439-1

7 January 2021

Cyclic-3',5'-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902439-1

7 January 2021

Zaprinast accelerates recovery from established acute renal failure in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902439-1

7 January 2021

Inhibitors of cyclic nucleotide phosphodiesterase isozymes block renal tubular cell proliferation induced by folic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902439-1

7 January 2021

Antisense inhibition of phosphodiesterase expression

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902439-1

7 January 2021

Cyclic nucleotide phosphodiesterase 1C promotes human arterial smooth muscle cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902439-1

7 January 2021

Vinpocetine treatment in acute ischaemic stroke: a pilot single-blind randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902439-1

7 January 2021

Effects of olprinone, a new phosphodiesterase inhibitor, on gastric intramucosal acidosis and systemic inflammatory responses following hypothermic cardiopulmonary bypass

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902439-1

7 January 2021

Effect of cilostazol in patients with intermittent claudication: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902439-1

7 January 2021

Effects of cilostazol on angiographic restenosis after coronary stent placement

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902439-1

7 January 2021

Phosphodiesterase 4 inhibitors for the treatment of COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902439-1

7 January 2021

Inhibition of phosphodiesterase 4 in allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902439-1

7 January 2021

The new phosphodiesterase 4 inhibitor roflumilast is efficacious in exercise-induced asthma and leads to suppression of LPS-stimulated TNF-alpha ex vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902439-1

7 January 2021

Sildenafil in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902439-1

7 January 2021

Effect of sildenafil on subjective and physiologic parameters of the female sexual response in women with sexual arousal disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902439-1

7 January 2021

10.1016/S0090-4295(02)02439-1

Identifiers

DOI

1 reference

6 August 2017

1 reference